Search

Author/Creator Hibberd, M.

1. Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK‐438 (vonoprazan), a novel potassium‐competitive acid blocker, in healthy male subjects. Issue 7 (23rd February 2015)

Authors:
Jenkins, H.; Sakurai, Y.; Nishimura, A.; Okamoto, H.; Hibberd, M.; Jenkins, R.; Yoneyama, T.; Ashida, K.; Ogama, Y.; Warrington, S.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 41:Issue 7(2015)
Page Start:
636
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. The contribution of host genetics and environmental variation to immune response in gamma-herpesvirus infections. (December 2020)

Authors:
Sallah, N.; Miley, W.; Labo, N.; Carstensen, T.; Gurdasani, D.; Sandhu, M.; Kellam, P.; Hibberd, M.; Newton, R.; Whitby, D.; Barroso, I.
Journal:
International journal of infectious diseases
Issue:
Volume 101(2020)Supplement 1
Page Start:
408
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗